文献速递中医内科针灸推拿

电针通过VEGF/PI3K/Akt通路减轻COPD大鼠肺血管重塑

Electroacupuncture attenuates pulmonary vascular remodeling in a rat model of chronic obstructive pulmonary disease via the VEGF/PI3K/Akt pathway.
PubMed 文献 · Acupunct Med · 2022-02-25

该研究在COPD大鼠模型中观察电针(EA)对肺血管重塑的影响及VEGF/PI3K/Akt通路的作用。结果表明EA改善肺功能与组织病理,8周效果最佳,并降低肺微血管密度及VEGF、ET-1表达,抑制VEGF/PI3K/Akt通路相关蛋白与mRNA表达。

要点

  • 电针可改善COPD大鼠肺功能与肺组织病理,8周效果最佳。
  • 电针降低肺微血管密度及VEGF、ET-1等血管生成相关因子表达。
  • 电针抑制VEGF/PI3K/Akt通路相关蛋白与mRNA表达。

核心结论

  • 电针对COPD大鼠有获益,可能通过VEGF/PI3K/Akt通路减轻肺血管重塑。

研究设计与样本

  • 大鼠随机分为空白组、COPD模型组、电针组和假针刺组。
  • 电针组取GV14、BL13、BL23,每周3次;假针刺组在距传统穴位5-10 mm处浅刺并最小电刺激。
  • 治疗2、4、8周后根据肺功能、肺病理和炎症因子水平确定最佳疗程。

主要发现

  • 电针改善肺功能和肺组织病理,8周效果最佳。
  • 电针降低肺微血管密度及VEGF和ET-1表达。
  • 与未治疗和假针刺COPD大鼠相比,电针组VEGF、VEGFR2、ET-1 mRNA及VEGF、VEGFR2、p-VEGFR2、PI3K、Akt、p-Akt、mTOR、p-mTOR蛋白水平降低。

临床怎么用

  • 动物实验提示电针可能作为COPD肺血管重塑的辅助干预,但临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. Pulmonary vascular remodeling is the main pathological feature of COPD. Vascular endothelial growth factor (VEGF), the key regulator of angiogenesis, mediates activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which regulates the proliferation and migration of vascular endothelial cells and plays important roles in pulmonary angiogenesis and remodeling in COPD. Here, the efficacy of electroacupuncture (EA) with respect to regulation of microvascular remodeling induced by VEGF/PI3K/Akt was evaluated in a rat model of COPD. METHODS: Rats were randomly assigned to blank, COPD model, EA and sham acupuncture (SA) groups. Rats in the EA group received EA at GV14, BL13 and BL23 three times per week, while those in the SA group, as a control, received shallow and minimal electrostimulation at sites 5-10 mm away from the traditional acupuncture point locations. After 2, 4 and 8 weeks of treatment, the optimal treatment duration was determined according to the results of lung function, lung pathology and inflammatory factor levels. Then, microvessel density, protein levels and mRNA expression of selected VEGF/PI3K/Akt pathway intermediates were determined by immunofluorescence, immunohistochemistry and Western blot analysis, and mRNA qRT-PCR, respectively. RESULTS: EA improved lung function and lung tissue histopathology, with the best effect after 8 weeks of treatment, as noted by reduced density of lung microvessels and expression of angiogenesis-related factors (VEGF and endothelin (ET)-1). EA-treated COPD rats exhibited reduced VEGF, VEGF receptor 2 (VEGFR2), ET-1 mRNA and VEGF, VEGFR2, phosphorylated (p)-VEGFR2, PI3K, Akt, p-Akt, mammalian target of rapamycin (mTOR), and p-mTOR at the protein level in comparison with untreated and SA-treated COPD model rats. CONCLUSION: EA had beneficial effects on COPD in this animal model including reduced pulmonary vascular remodeling via mechanisms possibly related to the VEGF/PI3K/Akt pathway.

来源:Acupunct Med,查看原文。版权归原作者所有。

引用

  1. Zhang L, Tian Y, Zhao P, et al. Electroacupuncture attenuates pulmonary vascular remodeling in a rat model of chronic obstructive pulmonary disease via the VEGF/PI3K/Akt pathway. Acupunct Med. 2022. PMID: 35216533. doi:10.1177/09645284221078873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。